Hiroshi G. Mabuchi

Hiroshi G. Mabuchi's AcademicInfluence.com Rankings

Hiroshi G. Mabuchi

Physics

#6021

World Rank

#7923

Historical Rank

physics Degrees

Download Badge

Physics

Hiroshi G. Mabuchi's Degrees

PhD Physics University of California, Berkeley
Bachelors Physics California Institute of Technology

Why Is Hiroshi G. Mabuchi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hiroshi G. Mabuchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. (1990) (857)
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins (1989) (472)
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. (2003) (296)
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. (2002) (271)
Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia (1998) (261)
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion (2002) (258)
Intermediate‐density Lipoprotein and Cholesterol‐rich Very Low Density Lipoprotein in Angiographically Determined Coronary Artery Disease (1981) (256)
Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. (1985) (253)
Development of coronary heart disease in familial hypercholesterolemia. (1989) (250)
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. (1994) (249)
Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine. (1983) (198)
Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. (1986) (194)
A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. (1998) (180)
A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). (1987) (168)
Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. (1996) (167)
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. (2002) (167)
Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis (2001) (159)
Cardiac Aldosterone Production in Genetically Hypertensive Rats (2000) (157)
Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. (2008) (156)
Prevalence of metabolic syndrome in the general Japanese population in 2000. (2006) (155)
Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. (2000) (142)
Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: comparison with electrocardiographic and thallium exercise stress test results. (1995) (136)
Postprandial lipoprotein metabolism: VLDL vs chylomicrons. (2011) (133)
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). (2002) (131)
Coronary calcification and coronary atherosclerosis: site by site comparative morphologic study of electron beam computed tomography and coronary angiography. (1997) (130)
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. (2005) (127)
Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia. (2002) (123)
Clinical features of prognosis of Japanese patients with anomalous origin of the coronary artery. (1996) (121)
Vascular aldosterone in genetically hypertensive rats. (1997) (120)
A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia. (2002) (114)
Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia (2017) (114)
Causes of death in patients with familial hypercholesterolemia. (1986) (111)
Mutational analysis of ATP7B and genotype–phenotype correlation in Japanese with Wilson's disease (2000) (102)
Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. (2000) (102)
Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. (1977) (101)
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981. (1981) (100)
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300198-JLR200 (2004) (100)
Association of Estrogen Receptor-α Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia (2002) (99)
Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy (2002) (94)
Metabolic adjustments in normal and diabetic pregnancy. (1981) (94)
Serum lipid survey and its recent trend in the general Japanese population in 2000. (2005) (93)
Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. (2007) (93)
Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. (2011) (92)
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody (2015) (89)
NK-104: a novel synthetic HMG-CoA reductase inhibitor (2000) (86)
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. (1991) (85)
Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats (2001) (85)
Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. (1998) (85)
Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry. (2018) (84)
Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle‐aged Japanese (2010) (83)
Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. (2003) (81)
Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. (1996) (81)
High Incidence of Sudden Cardiac Death With Conduction Disturbances and Atrial Cardiomyopathy Caused by a Nonsense Mutation in the STA Gene (2005) (79)
Alterations of lipoprotein(a) in patients with diabetic nephropathy. (1990) (78)
Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging (1998) (76)
Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. (2009) (76)
Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction. (2004) (76)
Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens (2001) (76)
Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease (2018) (75)
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia. (2002) (72)
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. (2014) (72)
Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Hokuriku NK-104 Study Group. (2000) (71)
Cholesteryl ester transfer protein and atherosclerosis (2000) (69)
Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. (2006) (67)
Iron accumulation in the liver of male patients with Wilson's disease (2001) (67)
Clinical Efficacy of Pitavastatin, a New 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, in Patients with Hyperlipidemia (2002) (66)
A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. (2002) (65)
Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. (1991) (64)
Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population. (2002) (64)
Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. (2004) (63)
Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. (2018) (63)
Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. (2000) (62)
Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism (2003) (61)
Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations. (2016) (61)
Mechanisms of FK 506-induced hypertension in the rat. (1999) (61)
Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. (2002) (61)
Arrhythmias in patients with Brugada-type electrocardiographic findings. (2001) (61)
Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan (2017) (61)
A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. (1989) (60)
Differentiation between patients with takotsubo cardiomyopathy and those with anterior acute myocardial infarction. (2005) (60)
Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. (1992) (60)
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis. (2002) (60)
A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. (2003) (59)
Homozygous familial hypercholesterolemia in Japan. (1978) (59)
Risk of Colorectal Neoplasm in Patients with Acromegaly and its Relationship with Serum Growth Hormone Levels (2005) (58)
Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. (1997) (58)
The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation. (2010) (58)
Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene. (1999) (57)
Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism. (2015) (55)
Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. (2005) (55)
Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. (1999) (54)
Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography. (2015) (54)
Lipoprotein lipase and atherosclerosis (1998) (51)
Angiotensin Converting Enzyme Inhibitors Are Associated with the Need for Increased Recombinant Human Erythropoietin Maintenance Doses in Hemodialysis Patients (1997) (50)
Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia. (1987) (50)
Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors (2014) (50)
Effect of walking with a pedometer on serum lipid and adiponectin levels in Japanese middle-aged men. (2006) (49)
Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. (2002) (49)
Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan. (1999) (48)
Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. (2002) (48)
A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene. (2011) (46)
Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT). (2005) (45)
Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy (2001) (45)
The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients. (1982) (45)
Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia. (1978) (44)
Exome Sequencing in Suspected Monogenic Dyslipidemias (2015) (44)
Inhibition by somatostatin of insulin release from isolated pancreatic islets (1975) (44)
Cancer-Associated Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry. (2019) (44)
Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. (1981) (44)
Status of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP). (2005) (44)
Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. (2008) (42)
Current State of and Recent Trends in Serum Lipid Levels in the General Japanese Population (1996) (42)
New Variant of Low Density Lipoprotein Receptor Gene: FH×Tonami (1988) (42)
Telmisartan Treatment Decreases Visceral Fat Accumulation and Improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients (2007) (41)
Infantile Cases of Sitosterolaemia with Novel Mutations in the ABCG5 Gene: Extreme Hypercholesterolaemia is Exacerbated by Breastfeeding. (2015) (41)
Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. (2005) (41)
Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study. (2011) (40)
Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma (2010) (40)
The expression of steroidogenic enzyme genes in human vascular cells (1996) (40)
Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. (2005) (38)
Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis. (1986) (38)
Iron accumulation in the liver of male patients with Wilson's disease. (2001) (38)
Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases. (1999) (38)
Serum lipoprotein lipase mass: clinical significance of its measurement. (2007) (37)
Carotid artery intima‐media thickness and brachial artery flow‐mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes (2002) (37)
Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT). (2007) (37)
Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo (2012) (37)
Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus (2002) (36)
Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. (2007) (36)
Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan. (1977) (36)
B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis (2018) (36)
Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. (2004) (36)
Comparison of Effects of Pitavastatin and Atorvastatin on Plasma Coenzyme Q10 in Heterozygous Familial Hypercholesterolemia: Results From a Crossover Study (2008) (36)
Gene mutations in adult Japanese patients with dilated cardiomyopathy. (2005) (36)
Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia. (1979) (35)
Retinoid X receptor heterodimer variants and cardiovascular risk factors. (2009) (35)
A Novel Missense Mutation in the SCN5A Gene Associated with Brugada Syndrome Bidirectionally Affecting Blocking Actions of Antiarrhythmic Drugs (2005) (34)
Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population (2001) (34)
Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. (1981) (33)
Prevalence of the metabolic syndrome in elderly and middle-aged Japanese (2010) (33)
Enzyme immunoassay for cholesteryl ester transfer protein in human serum. (1998) (33)
Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency. (1997) (33)
ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. (2005) (33)
Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. (2001) (33)
Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium. (2005) (33)
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis. (2005) (32)
1,5-Benzoxathiepin derivatives. II. Synthesis and serotonin S2-receptor-blocking activity of aminoalkyl-substituted 3,4-dihydro-2H-1,5-benzoxathiepin-3-ols and related compounds. (1987) (32)
Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia. (2000) (32)
Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. (2005) (31)
PRKAR1A gene mutation in patients with cardiac myxoma. (2005) (30)
Genetic analysis of the cytochrome P‐450c17α (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17α‐hydroxylase deficiency (2001) (30)
Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 1: influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men. (2003) (30)
Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease. (2001) (30)
Coronary artery bypass grafting in familial hypercholesterolemia. (1995) (30)
Clinical characteristics of Japanese patients with severe hypertriglyceridemia. (2015) (29)
Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry (2018) (29)
Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects. (2003) (29)
Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia. (1998) (29)
The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters. (2006) (29)
Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase. (2002) (28)
Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias (2003) (28)
Severe gastrointestinal complications of dialysis-related amyloidosis in two patients on long-term hemodialysis. (1996) (28)
Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia. (2012) (28)
Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy. (2002) (27)
Simultaneous, clonally identical T cell expansion in tonsil and synovium in a patient with rheumatoid arthritis and chronic tonsillitis. (2003) (27)
Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation. (2002) (26)
Identification of two novel missense mutations (p.R1221C and p.R1357W) in the ABCC6 (MRP6) gene in a Japanese patient with pseudoxanthoma elasticum (PXE). (2004) (26)
Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP. (2005) (26)
Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin. (2006) (26)
Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein. (2009) (26)
LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. (1999) (26)
Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome. (2002) (26)
Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients. (2009) (25)
Raloxifene promotes adipocyte differentiation of 3T3-L1 cells. (2006) (25)
An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese. (2002) (25)
Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. (1999) (25)
Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities. (2002) (25)
Primary Cardiovascular Events and Serum Lipid Levels in Elderly Japanese with Hypercholesterolemia Undergoing 6‐Year Simvastatin Treatment: A Subanalysis of the Japan Lipid Intervention Trial (2004) (24)
Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 (ABCA1) gene in Japanese patients with Tangier disease (2002) (24)
Lipid Management in a Japanese Community: Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (2017) (24)
Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. (2003) (24)
Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia. (1981) (24)
Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III (2002) (24)
Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects (2005) (24)
Therapeutic effects of LDL apheresis in the prevention of atherosclerosis. (1999) (24)
Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension. (1997) (23)
Clinical and Electrophysiological Characteristics of Brugada Syndrome Caused by a Missense Mutation in the S5‐Pore Site of SCN5A (2005) (23)
Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3. (2020) (23)
Remnant lipoproteins and atherosclerotic cardiovascular disease. (2019) (22)
Assessments of Carotid Artery Plaque Burden in Patients With Familial Hypercholesterolemia. (2017) (22)
Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome. (2005) (22)
Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia (1995) (22)
Effects of gender on the number of diseased vessels and clinical outcome in Japanese patients with acute coronary syndrome. (2002) (22)
Autosomal recessive hypercholesterolemia: a mild phenotype of familial hypercholesterolemia: insight from the kinetic study using stable isotope and animal studies. (2015) (21)
Serum apolipoproteins in heterozygous familial hypercholesterolemia. (1992) (21)
A study of the clinical significance of lipoprotein (a) in nephrotic syndrome. (1991) (21)
A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes. (2009) (21)
Japan Atherosclerosis Society (JAS) guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases (2004) (21)
Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry. (2019) (21)
Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia. (2004) (21)
Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia. (1996) (21)
Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis. (2017) (20)
Clinical efficacy and safety of rosuvastatin in Japanese patients with heterozygous familial hypercholesterolemia. (2004) (20)
Acute urinary retention as an unusual manifestation of aseptic meningitis. (2002) (20)
High Frequency of a Retinoid X Receptor &ggr; Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia (2007) (20)
Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia. (1987) (20)
A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing. (2016) (20)
Risk Factors for Coronary Heart Disease in the Japanese — Comparison of the Background of Patients with Acute Coronary Syndrome in the ASPAC Study with Data Obtained from the General Population (2002) (20)
Pseudohomozygous type II hyperlipoproteinemia (1982) (20)
Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. (2007) (20)
Effect of L-Carnitine and Palmitoyl-L-Carnitine on Erythroid Colony Formation in Fetal Mouse Liver Cell Culture (1998) (20)
Low‐density Lipoprotein Apheresis Therapy With a Direct Hemoperfusion Column: A Japanese Multicenter Clinical Trial (2006) (20)
Hemodynamic changes and prognosis in patients with hypertrophic cardiomyopathy and abnormal blood pressure responses during exercise (2003) (19)
Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants. (2005) (19)
QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy (2003) (19)
Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer. (1997) (19)
CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia. (2006) (19)
Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia (1996) (19)
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. (2002) (19)
Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain (2016) (18)
Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer (2020) (18)
Reduction of hemolysis without reoperation following mitral valve repair. (2003) (18)
The Risk of Cardiovascular Events in Japanese Hypertensive Patients with Hypercholesterolemia: Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a Large-Scale Observational Cohort Study (2005) (18)
Plasma homocysteine level and development of coronary artery disease. (1999) (18)
Assessment of arterial stiffness in patients with familial hypercholesterolemia. (2017) (18)
Treatment of Congenital Nephrogenic Diabetes insipidus with Hydrochlorothiazide and Amiloride in an Adult Patient (2004) (18)
Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT). (2002) (18)
Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis. (1988) (17)
Clinical characteristics of polycystic kidney disease with end-stage renal disease. The Kanazawa Renal Disease Study Group. (1998) (17)
Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry (2019) (17)
The first reported case of spotted fever in Fukui Prefecture, the northern part of central Japan. (2005) (17)
Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 2: association of lipid parameters with hypertension. (2003) (17)
Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia. (2004) (17)
Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells. (2003) (17)
Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference. (2009) (17)
Effects of coenzyme Q(10) on LDL oxidation in vitro. (2013) (17)
Effects of metabolic control on ventricular function in type 2 diabetic patients. (1992) (17)
Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy (2008) (17)
Oxidative stress correlates with left ventricular volume after acute myocardial infarction. (2002) (17)
Microvascular ischemia in patients with myotonic dystrophy. (2000) (16)
Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene. (2015) (16)
Normalization of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia. (1985) (16)
Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia (2018) (16)
Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT) (2000) (16)
Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection Fraction (2019) (16)
Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism (2006) (16)
Right ventricular metastasis from a primary cervical carcinoma. (2001) (16)
Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy. (2000) (15)
Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension. (2003) (15)
Cardiac Dysfunction and Long-Term Prognosis in Patients with Nonobstructive Hypertrophic Cardiomyopathy and Abnormal 123I-15- (p-Iodophenyl)-3(R,S)-Methylpentadecanoic Acid Myocardial Scintigraphy (2000) (15)
Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system. (1988) (15)
Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH). (2005) (15)
Post‐prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia (2012) (15)
A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes. (1982) (15)
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency. (1997) (15)
Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes (2005) (15)
[Selective hypoaldosteronism with hyperreninemia in a diabetic patient (author's transl)]. (1978) (15)
Mutation Analysis of the PTEN/MMAC1 Gene in Japanese Patients with Cowden Disease (2000) (15)
Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy. (2010) (14)
Propranolol for probucol-induced QT prolongation with polymorphic ventricular tachycardia (1993) (14)
A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. (2006) (14)
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients with Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3). (2021) (14)
Hereditary angioedema complicated with chronic renal failure: report of sibling cases. (1992) (13)
Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry (2018) (13)
Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivatives. (1994) (13)
Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia. (2009) (13)
Novel gene mutations at the low density lipoprotein receptor locus: FH‐Kanazawa and FH‐Okayama (1990) (13)
Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction. (2002) (13)
Remnant-like particles and coronary artery disease in familial hypercholesterolemia. (2018) (13)
Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population. (2007) (13)
Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study. (2011) (13)
Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype. (2004) (13)
Therapy: PCSK9 inhibitors for treating familial hypercholesterolaemia (2015) (13)
Coronary ectasia in a homozygous patient with familial hypercholesterolemia. (1986) (13)
Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis. (1998) (13)
Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis. (2010) (13)
Transcatheter Aortic Valve Implantation vs. Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Real-World Clinical Practice. (2020) (13)
Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia. (2009) (12)
Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation. (2002) (12)
Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemia. (2006) (12)
Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Risks of Cardiac Disease in Dialysis Patients Study Group. (1997) (12)
Molecular and functional characterization of familial chylomicronemia syndrome. (2017) (12)
Images in cardiology. Non-invasive detection of quadricuspid aortic valve. (1997) (12)
The expression of messenger RNA for ADP‐ribosyl cyclase in aldosterone‐producing adenomas (2005) (12)
Lipoprotein Apheresis for Sitosterolemia (2017) (12)
Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamsters. (1995) (12)
Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Arg92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy‐like features (2003) (12)
Spontaneous development of left ventricular aneurysm in a patient with untreated cardiac sarcoidosis. (2002) (12)
Long‐term Effect of Low‐density Lipoprotein Apheresis in Patients with Heterozygous Familial Hypercholesterolemia (2003) (12)
Insulin-releasing effect of quinaldic acid and its relatives on isolated Langerhans islets. (1973) (12)
Q-T peak dispersion in congenital long QT syndrome: possible marker of mutation of HERG. (2003) (11)
Up-Regulation of cyr61 in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats (2003) (11)
Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol. (2016) (11)
Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia. (2003) (11)
Diagnostic usefulness of the post-exercise systolic blood pressure response for the detection of coronary artery disease in patients with diabetes mellitus. (2000) (11)
A family of familial hypercholesterolemia with cerebral infarction and without coronary heart disease An unusual case with corneal opacity, polyneuropathy and carpal tunnel syndrome in the family: Therapy with probucol and tocopherol nicotinate (1991) (10)
The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients. (2007) (10)
Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study. (2002) (10)
A new variant deletion of a copper-transporting P-type ATPase gene found in patients with Wilson's disease presenting with fulminant hepatic failure (2000) (10)
Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women. (2016) (10)
Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia. (2014) (10)
A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load (2009) (10)
Decreased expression of 20‐kD homologous restriction factor (HRF20, CD59) on T lymphocytes in Epstein–Barr virus (EBV)‐induced infectious mononucleosis (1997) (10)
Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry). (2018) (10)
Sixteen-slice computed tomography, transthoracic real-time 3-dimensional echocardiography and magnetic resonance imaging assessment of a long-term survivor of rupture of sinus of valsalva aneurysm. (2005) (10)
Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT) (2007) (10)
Effect of Bilirubin UDP Glucuronosyltransferase 1 Gene TATA Box Genotypes on Serum Bilirubin Concentrations in Chronic Liver Injuries (2000) (10)
Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry. (2019) (10)
Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects. (2012) (10)
Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia. (2001) (10)
Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE Registry. (2020) (9)
An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statin. (2009) (9)
Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism　- From the COMMAND VTE Registry. (2019) (9)
A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing. (2016) (9)
ApoVLDL of the Watanabe Heritable Hyperlipidemic rabbit and the cholesterol-fed rabbit. (1984) (9)
Coronary Artery Disease Without Standard Cardiovascular Risk Factors. (2021) (9)
The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry. (2019) (9)
A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis. (1983) (9)
Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia. (2015) (9)
Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests. (1991) (8)
Surgical stress‐induced transient nephrogenic diabetes insipidus (NDI) associated with decreased Vasopressin receptor2 (AVPR2) expression linked to nonsense‐mediated mRNA decay and incomplete skewed X‐inactivation in a female patient with a heterozygous AVPR2 mutation (c. 89–90 delAC) (2004) (8)
Sarcopenia Predicts Adverse Outcomes in an Elderly Outpatient Population with New York Heart Association Class II–IV Heart Failure: A Prospective Cohort Study (2019) (8)
Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice (2019) (8)
Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis: a 28-year clinical course. (2005) (8)
Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry (2019) (8)
Inhibition effect of quinaldic acid on glucose-induced insulin release from isolated Langerhans islets of the rat. (1974) (8)
Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome. (2002) (8)
Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort st (2008) (8)
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis (2018) (8)
Images in cardiovascular medicine. Free-floating thrombus in right heart and massive pulmonary embolism migrating into pulmonary artery. (2005) (8)
Decreased serum cholesteryl-ester transfer activity in a patient with familial hyper-alpha-lipoproteinemia. (1988) (8)
1,5-Benzoxathiepin derivatives. I. Synthesis and reaction of 1,5-benzoxathiepin derivatives. (1987) (8)
Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia (2018) (7)
Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes (2008) (7)
Lecithin: cholesterol acyl transfer rate in hypothyroidism and hyperthyroidism. (1982) (7)
19-Noraldosterone in pregnancy-induced hypertension (2002) (7)
Acute increases in plasma oxidized low-density lipoprotein immediately after percutaneous transluminal coronary angioplasty. (2001) (7)
Diabetes progression from "high-normal" glucose in school teachers. (2010) (7)
Prognostic Impact of Peak Aortic Jet Velocity in Conservatively Managed Patients With Severe Aortic Stenosis: An Observation From the CURRENT AS Registry (2017) (7)
Abdominal Aortic Aneurysms in Familial Hypercholesterolemia—Case Reports (1993) (7)
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy (2016) (7)
Four unrelated cases with Takayasu arteritis and CD36 deficiency: possible link between these disorders (2004) (7)
Regulation of fatty acid synthesis in isolated hepatocytes by intestinal chylomicrons and their remnants (1979) (7)
In-hospital outcome in octogenarians with acute coronary syndrome undergoing emergent coronary angiography. (2003) (7)
Utility of simplified PESI score for identification of low-risk pulmonary embolism patients with active cancer: From the COMMAND VTE Registry. (2019) (7)
Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia. (1998) (7)
Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population (2004) (7)
Kinetic phenotypic diagnosis of N-acetylation polymorphism in patients based on ratio of urinary metabolites of salicylazosulfapyridine. (2001) (7)
Nephrotic syndrome due to focal glomerulosclerosis and undifferentiated carcinoma. (2000) (7)
Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine‐induced hypertension (2000) (7)
Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis. (1988) (7)
Ultrafast computed tomography in the diagnosis and evaluation of anomalous origin of the right coronary artery. (1995) (7)
Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy (2000) (7)
Effect of FK 506 on the Expression of Endothelin Receptor mRNA in the Vasculature (1995) (7)
Association of coronary artery ectasia with plasma insulin levels in Japanese men of heterozygous familial hypercholesterolemia with the low-density lipoprotein receptor gene mutation K790X. (2005) (6)
methods A novel method for measuring human hepatic lipase activity in postheparin plasma (2007) (6)
Use of LDL-apheresis in the management of familial hypercholesterolemia (1990) (6)
[Molecular mechanism of reverse cholesterol transport]. (2007) (6)
Effects of Fenofibrate Therapy on Plasma Ubiquinol‐10 and Ubiquinone‐10 Levels in Japanese Patients with Hyperlipidemia and Type 2 Diabetes Mellitus (2006) (6)
Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man. (1996) (6)
The relationship between post-prandial plasma glucose and post-challenge plasma glucose in Japanese population. (2007) (6)
Decreased serum cholesteryl-ester transfer activity in a patient with familial hyperalphalipoproteinemia. (1988) (6)
Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset　- From the COMMAND VTE Registry. (2019) (6)
Molecular Genetics of Cholesterol Transport and Cholesterol Reverse Transport Disorders (Familial Hypercholesterolemia and CETP Deficiency) and Coronary Heart Disease (1994) (6)
Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG. (2000) (6)
D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry (2019) (6)
Cavernous haemangioma in the coronary sinus (1998) (6)
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry (2019) (6)
Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia (1993) (6)
[A case of familial hypercholesterolemia associated with Schnyder's corneal dystrophy]. (1988) (6)
A novel method for measuring human hepatic lipase activity in postheparin plasma Published, JLR Papers in Press, November 7, 2006. (2007) (6)
Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy. (2001) (6)
A case of hyperLp(a)aemia, associated with systemic lupus erythematosus, suffering from myocardial infarction and cerebral infarction. (1990) (6)
Two novel mutations of PTEN gene in Japanese patients with Cowden syndrome (2004) (6)
Reasons for Choosing Conservative Management in Symptomatic Patients With Severe Aortic Stenosis　- Observations From the CURRENT AS Registry. (2019) (5)
Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes. (2004) (5)
Abnormal sympathetic innervation of the heart in a patient with Emery-Dreifuss muscular dystrophy (2005) (5)
Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial. (2005) (5)
Studies on Antiandrogenic Agents. Synthesis of 16β-Ethyl-19-nortestosterone (1975) (5)
Evidence for regression of coronary atherosclerosis effected by LDL-apheresis in a patient with familial hypercholesterolemia (1994) (5)
Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes. (2006) (5)
Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia. (1992) (5)
A case of spontaneous closure of coronary artery fistula with familial hypercholesterolaemia (2002) (5)
Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemia (2000) (5)
Impact of no, distal, and proximal deep vein thrombosis on clinical outcomes in patients with acute pulmonary embolism: From the COMMAND VTE registry. (2020) (5)
Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect (2007) (4)
[Diagnosis of type III hyperlipemia. VLDL-cholesterol and the VLDL-cholesterol/VLDL-triglyceride ratio]. (1977) (4)
[Hyperlipidemia and arteriosclerosis]. (1998) (4)
Changes in cardiac tissue characterization in carriers with gene mutations associated with hypertrophic cardiomyopathy. (2005) (4)
A possible new syndrome with double endocrine tumors in association with an unprecedented type of familial heart-hand syndrome: a case report (2010) (4)
L-Carnitine Supplementation in a Hemodialysis Patient with a Mutation in the Mitochondrial tRNALeu(UUR) Gene (2000) (4)
Correlation between myocardial dysfunction and changes in myosin isoenzymes in diabetic rat hearts. (1996) (4)
A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease. (2001) (4)
Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes. (1982) (4)
Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT study. (2005) (4)
Clinical whole exome sequencing in severe hypertriglyceridemia. (2019) (4)
Long Term Effect of LDL Apheresis in Japan (1991) (4)
Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterol (2006) (4)
Marked transient hypercholesterolemia caused by low-dose mitotane as adjuvant chemotherapy for adrenocortical carcinoma. (2014) (4)
[Cholesteryl ester transfer protein (CETP) deficiency and increased HDL cholesterol levels (hyperalphalipoproteinemia)]. (1996) (4)
Systolic dysfunction and blood pressure responses to supine exercise in patients with hypertrophic cardiomyopathy. (2001) (4)
Collagen synthesis by cultured cardiac fibroblasts obtained from cardiomyopathic hamsters. (1998) (4)
Age-Related Differences in the Effects of Initial Aortic Valve Replacement vs. Conservative Strategy on Long-Term Outcomes in Asymptomatic Patients With Severe Aortic Stenosis. (2019) (4)
Strategy for treating elderly Japanese with hypercholesterolemia * (2004) (3)
Quantitative assessment of diffuse coronary artery disease using a three‐dimensional reconstruction method compared with intravascular ultrasound images (2001) (3)
Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry. (2021) (3)
Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method (2015) (3)
Serum and lipoprotein lipid levels in diabetic patients with familial hypercholesterolemia. (1983) (3)
1FS03-4 Japan atherosclerosis society (JAS) guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases (2003) (3)
Clinical and Electrophysiological Characteristics of Brugada Syndrome Caused by a Missense Mutation in the S5-pore site of SCN5A(Arrhythmia, Diagnosis/Pathophysiology/EPS 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (3)
[Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty]. (2001) (3)
Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor gene. (2005) (3)
Effect of bilirubin UDP-glucuronosyltransferase 1 gene tata box on serum bilirubin concentrations in chronic liver injury (1998) (3)
A massive pulmonary hemorrhage resulting in cavitation occurring in a case of hemophilia A associated with diabetes mellitus. (1974) (3)
CETP(Cholesteryl Ester Transfer Protein) Deficiency Caused by Genetic Mutation in the CETP Gene in Normal Korean Population (1996) (3)
Increased matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction (2002) (3)
Diagnostic Criteria for Familial Hypercholesterolemia in Japan (1977) (3)
Analysis of Responses of Clinical Pharmacists to Questions on Drugs from Medical Staff and Their Effect on Therapy (2005) (3)
Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency) and coronary heart disease. (1995) (3)
Chemical Transformation of 3’-Chloro-3’-deoxyaminoglycosides into New Cyclic Pseudo-trisaccharides (1978) (3)
Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study. (2019) (3)
Hyperlipemia and arteriosclerosis. (1998) (3)
Comparison of the effects of losartan vs. ramipril on several adipocytokines and vascular remodeling biomarkers (2011) (3)
Synthesis and platelet-activating factor (PAF)-antagonistic activities of trisubstituted piperazine derivatives. (1994) (2)
Effects of Long-Term Probucol Treatment on Serum Lipids, Lipoprotein Lipids and Skin Xanthomas in Heterozygous Familial Hypercholesterolemic Patients (1983) (2)
Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3). (2021) (2)
[High density lipoprotein]. (2001) (2)
Analysis of ankyrin-B gene mutations in patients with long QT syndrome. (2006) (2)
Studies on urinary and serum volatile substances. (1969) (2)
Abstract 1921: Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients: Evidence From Familial Gene Analysis (2008) (2)
Long-term efficacy of immunoadsorbent plasmapheresis in a patient with Budd-Chiari syndrome due to antiphospholipid syndrome: case report with nine-year follow-up (2004) (2)
2P-0607 The current status of lipid-lowering therapy for hyperlipidemia in Japan: Japan Lipid Assessment Program (J-LAP) (2003) (2)
Irrigation of liver abscess: proposal of a novel method and possible indications. (2001) (2)
[Dyslipidemia in insulin resistance and its improvement by troglitazone]. (2000) (2)
Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism (2010) (2)
Studies on the Diagnosis of Type III Hyperlipoproteinemia A suggestion of chemical criteria based on VLDL-cholesterol and VLDL-cholesterol/VLDL-triglyceride (1977) (2)
Impact of adiposity on carotid atherosclerosis in Japanese males with metabolic syndrome (2005) (2)
[Recent trend in the research of hyperlipidemia in Japan (2). Molecular genetics and clinical features of familial hypercholesterolemia]. (1989) (2)
Thirty Years of Statins, Festschrift in honor of Dr. Akira Endo. (2004) (2)
Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo: response to Schneider et al. (2006) (2)
TWO MALE PATIENTS WITH WILSON's DISEASE TREATED USING TRIENTINE AND IRON REDUCTION THERAPY (2005) (2)
Denaturing gradient gel electrophoresis analysis of the low density lipoprotein receptor gene and the apolipoprotein B-100 gene in Japanese patients with familial hypercholesterolemia (1999) (2)
A case of portal vein thrombosis. Bacteroidal pylethrombosis and changing clinical pictures. (1997) (2)
[A quantitative evaluation of coronary steal phenomenon in coronary artery-pulmonary artery fistula: case report]. (1995) (2)
A Rare Type of Alternating Bundle Branch Block in a Patient with Cardiac Sarcoidosis (2005) (2)
Mutations in the Low Density Lipoprotein Receptor Gene in Japanese Patients with Familial Hypercholesterolemia (1990) (2)
An unsolved mystery of promoter variation in CETP gene and atherosclerosis (2001) (2)
Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry). (2019) (2)
MTP inhibitor for treating severe LDL cholesterolemia (2013) (2)
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism (2021) (2)
[An autopsied case of adult onset Still's disease accompanied by fatal liver failure, and simultaneously complicating adenocarcinomatous peritonitis from unidentified primary site]. (1997) (2)
P5381Post-prandial remnant lipoprotein metabolism in sitosterolemia (2018) (1)
The Effects of LDL-Apheresis and Plasma Exchange on Cholesterol Level and Lipid Composition of Low and High Density Lipoproteins in Homozygous Patients with Familial Hyper-Cholesterolemia (1988) (1)
Common Mutation of 5, 10-Methylenetetrahydrofolate Reductase Accelerates Coronary Artery Disease in Familial Hypercholesterolemia (2000) (1)
P18-3 - Gender Difference in Acute Myocardial Infarction (2017) (1)
Abstract: P979 ENHANCED EFFECT OF BEZAFIBRATE ON HDL SUBFRACTIONS IN PATIENTS WITH DYSBETALIPOPROTEINEMIA: RESULTS FROM A CROSSOVER STUDY WITH ATORVASTATIN (2009) (1)
[New guideline for the management of hyperlipidemia according to patient category and global risk chart]. (2002) (1)
Effects of Combined Therapy Using Two Kinds of HMG-CoA Reductase Inhibitors in Heterozygous Familial Hypercholesterolemia (1999) (1)
LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 GAIN-OF-FUNCTION MUTATIONS: IMPLICATION OF RESIDUAL RISK IN STATIN-ERA (2015) (1)
[Familial defective apolipoprotein B-100: FDB]. (2007) (1)
Effects of ML-236 B ( Compactin ) on Sterol Synthesis and Low Density Lipoprotein Receptor Activities in Fibroblasts of Patients with Homozygous Familial Hypercholesterolemia (2013) (1)
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays (2020) (1)
LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS (2016) (1)
Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry. (2020) (1)
Abstract 18143: Impact of FMO3 Gene Loss-of-Function Variants on Coronary Artery Disease in Japanese (2014) (1)
[A case of pseudoxanthoma elasticum associated with familial hypercholesterolemia (author's transl)]. (1981) (1)
Abstract 17785: Eicosapentaenoic Acid Add-on to Atorvastatin Normalizes Pre-{beta}1-HDL Levels (2010) (1)
A Case of Familial Polyposis Coli in a Patient with Multiple Colon Cancer in the Region of Colostomy (1994) (1)
Incidence of Familial Hypercholesterolemia: -Data Based on a Population Sample of 16, 940 Persons Aged 20 Years-@@@―20歳検診16,940人の成績から― (1983) (1)
[A case of chylomicronemia with chronic relapsing pancreatitis (author's transl)]. (1974) (1)
A large deletion of ABC1 gene in a Japanese patient with Tangierdisease (2000) (1)
Abstract 13869: Statin Therapy Improves Fractional Catabolic Rate of LDL without Affecting Impaired VLDL and VLDL Remnant Catabolism in Homozygous FH Patient Due to PCSK9 Gene Mutation: Evidence from Kinetic Study with Stable Isotope (2012) (1)
Achilles Tendon Thickness of Familial and Secondary Hypercholesterolemic Patients (1976) (1)
4P-1030 Diplotype analysis identified lower expression haplotype of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism (2003) (1)
Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry (2021) (1)
P-214 Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients (2009) (1)
[Response of coronary arteries to intracoronary acetylcholine infusion in patients with familial hypercholesterolemia]. (1992) (1)
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan　- From the CREDO-Kyoto Registry Cohort-2 and Cohort-3. (2021) (1)
Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia. (2000) (1)
Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. (2000) (1)
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of HDL-cholesterol in a general Japanese population (1994) (1)
Abstract: P860 IMPACT OF RAPID DEVELOPMENT OF CAROTID ATHEROSCLEROSIS IN YOUNG FAMILIAL HYPERCHOLESTEROLEMIA (FH): COMPARISON WITH NON-FH LITTERMATES (2009) (1)
A New Variant of Low Density Lipoprotein Receptor Gene and its Application to Neonatal Diagnosis of Familial Hypercholesterolemia (1988) (1)
Gene analysis of CFTR in japanese patients with chronic pancreatitis (2000) (1)
[Primary and secondary prevention of atherosclerotic disease by lipid-lowering therapies]. (1999) (1)
[Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis]. (1993) (1)
Cholesterol Synthesis and Low Density Lipoprotein Receptor Activity in Mononuclear Cells Freshly Isolated from the Patients with or without Familial Hypercholesterolemia (1984) (1)
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization (2022) (1)
Contents Vol. 72, 1999 (2000) (1)
Normal Range of Serum Lipids: -Data Based on a Population Study of 20-year-old Persons and a Family Study of Familial Hyperlipidemias-@@@―成年(20歳)健康調査と家族性高脂血症の家族調査より― (1987) (1)
Vasomotor response to acetylcholine and its correlates with serum lipid levels in early postmenopausal women (2000) (1)
[KLAS [Kanazawa Lipid Assessment Survey]]. (2001) (1)
[Familial defective apolipoprotein B100: FDB]. (2001) (1)
Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosis (2020) (1)
Effect of Probucol on Serum Lipoprotein Lipids in Patients with Familial Hypercholesterolemia: -Changes in HDL Subfraction-@@@―HDL 2 , HDL 3 の変動について― (1983) (1)
DNA Polymorphism in the Low Density Lipoprotein Receptor Gene (1987) (1)
2. Molecular Genetics and Clinical Features of Familial Hypercholesterolemia (1989) (1)
The distribution of fasting and non-fasting serum triglyceride levels in Japanese population. (2006) (1)
Clinical Features of Hypertrophic Cardiomyopathy Caused by a Novel Val85Leu Missense Mutation in the Cardiac Troponin T Gene(Cardiomyopathy, Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (1)
SCN5A Gene Mutations and Clinical Characteristics in Patients With Brugada-Type Electrocardiogram (2002) (1)
Studies on antiandrogenic agents. Synthesis of 16 beta-ethyl-19-nortestosterone. (1975) (1)
Successful Surgery of Right Common Iliac Artery Injury during Lumbar Discectomy with Endovascular Balloon Occlusion of the Aorta Performed by Cardiologists (2019) (1)
[Diagnostic criteria for familial hypercholesterolemia in Japan (author's transl)]. (1977) (1)
[CETP deficiency]. (1994) (1)
Association between Single Nucleotide Polymorphisms (SNPs) of Cardiac Potassium Channel Genes and Drug-Induced Long QT Syndrome in Japanese (2003) (0)
AKIRA ENDO: THE DISCOVERY OF STATINS (2014) (0)
Abstract 9603: Extreme Hypercholesterolemia Exacerbated by Breast Feeding: Infantile Cases of Sitosterolemia With Novel Mutations in ABCG5 Gene (2014) (0)
Hyperlipidemia produced by serum lipoprotein abnormalities or lipoprotein receptor mutations (1992) (0)
Relation between Serum Lipid and Lipoprotein Levels and the Degree of Coronary Artery Sclerosis Studied by Selective Coronary Cine-Angiography (1979) (0)
Abstract: 99 COENZYME Q10 REDUCTION WITH STATINS: ANOTHER PLEIOTROPIC EFFECT (2009) (0)
[Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia]. (1988) (0)
Risk Predictor of In-hospital Mortality after Acute Myocardial Infarction (2012) (0)
Probucol-Induced Long QT Syndrome Associated with a Novel Missense Mutation M124T in the N Terminus of HERG (2003) (0)
2P-0346 Relationship of lipid profile and gene polymorphism related to lipid metabolism in Japanese (2003) (0)
[Practice guidelines review: Hyperlipidemia]. (2002) (0)
Effects of VLCD therapy on lipid metabolism in obesity (2000) (0)
A case of autoimmune hepatitis combined with ventricular tachycardia. (1997) (0)
Cardiac troponin T mutation, Arg92Trp, linked to familial hypertrophic cardiomyopathy shows a high disease penetrance, moderate hypertrophy, and early progression to dilated cardiomyopathy-like features in Japanese (1999) (0)
Germline mutation of the PTEN gene in Japanese patients with Cowden disease (1998) (0)
Title Heterogeneity of cardiac sympathetic nerve activity and systolicdysfunction in patients with hypertrophic cardiomyopathy (2017) (0)
[Cowden disease]. (2000) (0)
A case of chronic active hepatitis complicated by hypertriglyceridemia due to interferon .BETA. treatment. (1995) (0)
Disorder of lipid metabolism.An advance on diagnosis and treatment.2.Various conformers of disorder of lipid metabolism.1.Primary hyperlipidemia.2.Hypercholesterolaemia. (1992) (0)
Rapid gastric emptying of liquids and poor mixing of milieu with digestive fluids cause long-term malnutrition after gastrectomy (2003) (0)
2P-0542 Diagnosis hyper-LDL-cholesterolemia by cutting point separating affected and non-affected familial hypercholesterolemic patients validated by LDL-receptor gene mutants (2003) (0)
Abstract 18157: Impact of Betatrophin (ANGPTL8) R59W Mutation for Future Diabetes, and Minimal Modification of Circulating Betatrophin With Strong Statins (2015) (0)
Decreased Serum Cholesteryl-ester Transfer Activity in the Patient with Familial Hyperalphalipoproteinemia (1987) (0)
Omeprazole and Diminished Antianginal Drug Delivery (1994) (0)
WHOLE EXOME SEQUENCING IN PRIMARY SEVERE HYPERTRIGLYCERIDEMIA (2016) (0)
OJ-229 Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy with Different Genotypes(Cardiomyopathy, Clinical 1 (M) : OJ26)(Oral Presentation (Japanese)) (2004) (0)
[Eosinophilic polymyositis]. (1996) (0)
A case of familial hypercholesterolemia receiving simultaneous coronary artery bypass grafting and replacement therapy by means of an artificial vessel to an abdominal aortic aneurysm (1990) (0)
Familial Hyperlipoproteinemia Type V (1979) (0)
1.P.248 Variety of low-density-lipoprotein-receptor gene mutations and expression of coronary artery disease in heterozygous familial hypercholesterolemia (1997) (0)
Effects of Probucol on Serum and Lipoprotein Lipids and Apoprotein Composition of VLDL Fractions (1984) (0)
Clinical and molecular characteristics of homozygous CETP deficiency (2000) (0)
Clinical characteristics of common PCSK9 gain-of-function E32K variant with higher TG elevation, and double heterozygotes with common PCSK9 variants and LDLR mutations (2016) (0)
Abstract 11571: Whole Exome Sequencing in Familial Hypobetalipoproteinemia (2015) (0)
[Hypo beta-lipoproteinemia with selective deletion of apo B-48]. (1998) (0)
FRI0126 Corticosteroid therapy-induced injury in patients with systemic lupus erythematosus (2001) (0)
Cholesteryl Ester Transfer Protein (CETP) Promoter-1337 C/T Polymorphism Protect Against Coronary Atherosclerosis in Patient With Familial Hypercholesterolemia (FH)(Lipid Disorders 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Prevalence and Onset of Hypertrophic Cardiomyopathy Caused by Thin Filament Gene Mutations(Cardiomyopathy, Clinical 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
2P-0448 Two prevalent mutations in the ATP-binding cassette transporters ABCC6 Japanese patients with pseudoxanthoma elasticum (PXE) (2003) (0)
Tissue Characteristics of Carotid Intima-media Complex Detected by Ultrasonic Integrated Backscatter (IBS) in Patients With Familial Hypercholesterolemia (FH)(Atherosclerosis, Clinical 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Abstract 20425: Metabolic Burden Switches Impact of Betatrophin (ANGPTL8) R59W Mutation From Atheroprotective to Atherogenic Lipid Profiles (2014) (0)
PE-396 Impact of New Insights of Lipoprotein Metabolism in Autosomal Recessive Hypercholesterolemia : A Stable Isotope Kinetic Study in Vivo(PE067,Lipid Disorders 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society) (2009) (0)
OJ-415 Electrocardiographic Events and Cholesterol Reduction with Pravastatin in Patients with Hypercholesterolemia : Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial(Preventive Medicine/Epidemiology/Education 3 (H) : OJ50)(Oral Presentation (Japanese)) (2004) (0)
Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- A Report From the CURRENT AS Registry. (2021) (0)
A CASE OF TYPE 3 HYPERLIPOPROTEINEMIA ASSOCIATED WITH XANTHOMATOSIS AND CORONARY ARTERIOSCLEROSIS MANIFESTED WITH DEVELOPMENT OF SHEEHANS SYNDROME (1977) (0)
Supplementary) Serum Lipoprotein and LDL Pathway in Familial Hypercholesterolemia (1981) (0)
[The diagnostic value of measurement of Achilles tendon thickness by skin fold caliper for discrimination of familial hypercholesterolemia and non-familial hypercholesterolemia (author's transl)]. (1980) (0)
Abstract 11169: Whole Exome Sequencing in Subjects With Mendelian Form of Primary Severe Hypertriglyceridemia (2016) (0)
Tu-P8:321 RXR-gamma and FXR variants affect serum cholesterol levels mainly through lipoprotein lipase levels (2006) (0)
Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Hypertrophic Cardiomyopathy(Cardiomyopathy, Clinical 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
[Abnormality of LDL receptor genes in familial hypercholesterolemia and the genetic diagnosis]. (1988) (0)
Molecular Genetics and Clinical Features of Japanese Patients with Familial Hypercholesterolemia (2000) (0)
Abstract 20170: Plasma Apolipoprotein C-III Levels Correlate With Malignant HDL-Lipid Composition Associated With Coronary Artery Disease in Primary Dyslipidemia (2015) (0)
Decreased SR-BI expression by CETP antisense treatment in HepG2 cells (2000) (0)
[Familial combined hyperlipidemia]. (2001) (0)
Studies on Type III hyperlipoproteinemia: Apoprotein E isoforms by gel isoelectric focusing method@@@等電点ゲル電気泳動法を用いたアポ蛋白Eの Isoform の検討 (1981) (0)
RXRγ Gene Variant is Associated with Higher BMI, Lower HDL-C, Advanced Coronary Artery Disease, and Frequent in Familial Combined Hyperlipidemia(The Frontier of Atherosclerosis Research (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
P-207 Impact of Co-Administration of Atorvastatin and Bezafibrate on the Lipoprotein Subclass: Comparison between apoE2/2 and apoE3/3 (2009) (0)
FRS-132 Phenotypic Discrepancies Between Electrocardiography and Echocardiography for Hypertrophic Cardiomyopathy in Genetically Affected Subjects(Myocardial Disease (M) : FRS16)(Featured Research Session (English)) (2004) (0)
[Studies on simple methods for quantitation of "serum beta-lipoprotein" (author's transl)]. (1978) (0)
Cardiac Manifestations and Long-Term Course in Emery-Dreifuss Muscular Dystrophy Caused by a Nonsense Mutation in the STA Gene (2003) (0)
Title Assessment of Coronary atherosclerosis in patients with familialhypercholesterolemia by coronary computed tomography angiography (2017) (0)
Abstract 1314: Impact of Increased Catabolism of VLDL Remnant in Autosomal Recessive Hypercholesterolemia: A Stable Isotope Kinetic Study in vivo (2009) (0)
Studies of Human Low Density Lipoprotein Receptor Gene (1986) (0)
Corrigendum to “A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia”: [ATH 162 (2002) 373–379] (2003) (0)
QT Variables in Preclinical Patients with Hypertrophic Cardiomyopathy (2003) (0)
[Familial hyperlipidemia in the aged]. (1993) (0)
1.W05.4 Lessons from molecular defects in secretion, transport and reverse transport of cholesterol (1997) (0)
MS29 USEFULNESS OF DNA ANALYSIS FOR THE DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND EXTRAORDINARILY HIGH FREQUENCY OF FH IN JAPAN (2010) (0)
Genetics of Low Density Lipoprotein Receptor Mutations in Fibroblasts of Patients with Homozygous Familial Hypercholesterolemia (1981) (0)
Decreased expression of scavenger receptor class B type I by cholesteryl ester transfer protein antisense inhibition in HepG2 cells (2001) (0)
Abstract: S3-7 HUMAN CETP DEFICIENCY AND CETP INHIBITION (2009) (0)
Serum Lipid and Lipoprotein Levels in Patients with Familial Hypercholesterolemia (1979) (0)
PJ-425 Early Development of Dilated Cardiomyopathy in Subjects with Mutations in the Cardiac Troponin Complex Genes(Cardiomyopathy, Clinical 5 (M) : PJ71)(Poster Session (Japanese)) (2004) (0)
[Familial hypercholesterolemia]. (1998) (0)
JACC March 19,2003 ABSTRACTS-Cardiac Arrhythmias 1llA (2016) (0)
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy (2016) (0)
OJ-511 Missense Mutations in Cardiac Ryanodine Receptor Gene Cause Hypertrophic Cardiomyopathy Associated with Ventricular Arrhythmia or Massive Hypertrophy(Cardiomyopathy, Basic (M) : OJ62)(Oral Presentation (Japanese)) (2004) (0)
Association of angiopoietin-like protein3 (ANGPTL3) with HTGL and LPL activities in human plasma (2010) (0)
P6240Assessments of carotid plaque burden in patients with familial hypercholesterolemia (2017) (0)
Apolipoprotein A-I Gene Polymorphism in Patients with Coronary Heart Disease and Normolipidemic Controls (1987) (0)
[Nuclear receptor regulation of cholesterol metabolism]. (2001) (0)
P6269Remnant-like particles and coronary artery disease in familial hypercholesterolemia (2018) (0)
Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation. (2021) (0)
A Novel Mutation (lnt21DSG+1A) in the MyBP-C Gene Shows Hypertrophic Cardiomyopathy with a High Degree of Penetrance in Adult Patients (2003) (0)
Abstract 17990: Common PCSK9 Gain-of-function E32K Variant Carriers Reveal Milder LDL-C but Higher TG Elevation Compared With LDLR Mutations (2015) (0)
Left ventricular dysfunction and dilatation in elderly patients with hypertrophic cardiomyopathy associated with a novel missense mutation in MyBP-C gene (2002) (0)
-0435- RENAL ARTERIAL SCLEROSIS IN HETEROZYGOUS PATIENTS WITH FH(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY) (1995) (0)
Apolipoproteins of Patients with Familial Hypercholesterolemia and Model Animals (WHHL Rabbits) (1986) (0)
[Arteriosclerosis obliterans]. (1993) (0)
Abstract 18200: Sortilin Levels Correlated With Renal Function and Reduced by Strong Statins With Increased PCSK9 in Primary Dyslipidemia (2016) (0)
Mutation analysis in Japanese patients with Wilson's disease (1998) (0)
DPE-029 Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients : Evidence from Familial Gene Analysis(DPE05,Lipid Disorders (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society (2009) (0)
OJ-237 KCNJ2 Gene Mutation is a Rare Cause of Long QT Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese)) (2004) (0)
2.P.298 Current state of serum lipid levels in the general Japanese population - cholesterol and lipoprotein(a) (1997) (0)
OE-101 Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men(Cerebrovascular circulation/Stroke-1 (H) OE17,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Societ (2006) (0)
Ankyrin-B Gene Mutation is a Rare Cause of Long QT Syndrome in Japan(Arrhythmia, Basic 1 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Title In-hospital Outcome in Octogenarians with Acute Coronary SyndromeUndergoing Emergent Coronary Angiography (2017) (0)
Abstract: 532 MOLECULAR GENETIC EPIDEMIOLOGY OF FAMILIAL HYPERCHOLESTEROLEMIA IN HOKURIKU DISTRICT OF JAPAN (2009) (0)
Corrigendum to “Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population” [ATH 165 (2002) 335–342] (2004) (0)
[New approach to pathogenesis of genetic hyperlipoproteinemias]. (1993) (0)
Prevalence of Gene Mutations in Patients with Congenital Long QT Syndrome(Arrhythmia, Basic 2 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
cDNA Cloning of Human Apo-E and Analysis of the Apo-E Gene in a Patient with Apo-E Absence (1985) (0)
Coronary Atherosclerosis and Apolipoprotein(a)phenotype (1994) (0)
Abstract 9599: Coronary Plaque Burden Assessed With Coronary Computed Tomography Angiography Predicts Future Coronary Events in Patients With Familial Hypercholesterolemia (2014) (0)
WHOLE EXOME SEQUENCING IDENTIFIES RECESSIVE FORM OF FAMILIAL HYPOALPHALIPOPROTEINEMIA WITH COMPOUND HETEROZYGOUS MUTATIONS IN ATP-BINDING CASSETTE TRANSPORTER 1 GENE (2015) (0)
Abstract 9601: Early Coronary Atherosclerotic Morphology in Pseudoxanthoma Elasticum: Images From Intravascular Ultrasound and Optical Coherence Tomography (2014) (0)
Analysis of Genetic Factors in Hyperlipidemia (1990) (0)
Colorectal neoplasma in patients with acromegaly (1998) (0)
PE-252 Common Variant of Farnesoid-X-receptor Gene Enhances the Response to Lipid-Lowering Therapy(Lipid disorders-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Treatment of A Homozygous Patient with Familial Hypercholesterolemia by Adsorption Chromatography with Porous Glass (1984) (0)
Impact of loss of function variant of betatrophin on advanced coronary artery disease among diabetic patients in japan (2014) (0)
Cholesteryl Ester Transfer Protein (CETP) and Atherogenicity. Anti-atherogenicity of CETP deficiency is dependent on serum HDL cholesterol levels: ―CETP欠損症の抗動脈硬化性は血清HDLコレステロール値に依存する― (1998) (0)
Abstract 17748: Impact of Triglyceride-Rich High-Density Lipoprotein Composition on Development of Angiographic Coronary Artery Disease (2010) (0)
Abstract 11731: Oligogenic Familial Hypercholesterolemia, LDL Cholesterol, and Coronary Artery Disease (2017) (0)
1.P.189 Ldl-receptor genotype dependent response to cholesterol-lowering therapy in patients with heterozygous familial hypercholesterolemia (1997) (0)
Efficacy and safety of pravastatin 40 mg/day in Japanese patients with heterozygous familial hypercholesterolemia (1999) (0)
[Studies on the transition of "types" in hyperlipemia--some questions concerning "Frederickson's classification" of hyperlipemia]. (1975) (0)
Scintigraphic evaluation of regression of abnormal Q waves in myocardial infarction (2005) (0)
[Concept, definition, and reference for diagnosis of hypolipidemia]. (2007) (0)
Abstract 11567: A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing (2015) (0)
2.P.211 Plasma homocysteine levels and premature coronary artery disease in male patients (1997) (0)
PE-278 Electrocardiography Shows Preferable Diagnostic Value Even in Carriers of Hypertrophic Cardiomyopathy who do not Manifest Ventricular Wall Hypertrophy on Echocardiography(Cardiomyopathy, Clinical 3 (M) : PE48)(Poster Session (English)) (2004) (0)
Novel KCNQ1 missense mutation (D611Y) in a Japanese long QT family (2002) (0)
Hypolipoproteinemic Effects and Mechanisms of Action of Clofibrate and Probucol: ―プロブコールをふくむ― (1985) (0)
Abstract: P859 IMPACT OF ACCELERATION OF POST-PRANDIAL REMNANT LIPOPROTEIN CLEARANCE IN AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA (ARH) (2009) (0)
The influence of the bilirubin UDP-glucuronosyl-transferase-1 gene on bilirubin levels of chronic hepatitis C (1997) (0)
1.P.197 Long-term efficacy LDL-apheresis on coronary heart disease in familial hypercholesterolemic patients (1997) (0)
Abstract: P851 PROFILES OF GAIN-OF-FUNCTION PCSK9 E32K MUTATION: INCLUDING PURE HOMOZYGOTE AND COMPOUND HETEROZYGOTE WITH LDLR GENE MUTATION (2009) (0)
Title Oxidative Stress Correlates with Left Ventricular Volume after AcuteMyocardial Infarction (2017) (0)
Penicillin for hypercholesterolemia (2004) (0)
Association of Estrogen Receptor-&agr; Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia (2002) (0)
1,5-Benzoxathiepin Derivatives. Part 1. Synthesis and Reaction of 1,5-Benzoxathiepin Derivatives. (1987) (0)
Association Between ABCG5/G8 SNPs and Higher Cholesterol Absorption Marker in Hypercholesterolemia(Lipid Disorders 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
The Risk of Ischemic Heart Desease in Familial Hypercholesterolemia (1981) (0)
P4600Clinical utility of biwaco score for the patients with atrial fibrillation after percutaneous coronary intervention: biwaco study (2018) (0)
[Obesity and the related diseases: hyperlipidemia]. (1995) (0)
[Familial hypo beta-lipoproteinemia]. (1998) (0)
4P-1036 HDL subpopulation profile in CETP deficiency (2003) (0)
1,5-Benzoxathiepin Derivatives. Part 2. Synthesis and Serotonin S2-Receptor-Blocking Activity of Aminoalkyl-Substituted 3,4-Dihydro-2H-1,5benzoxathiepin-3-ols and Related Compounds. (1987) (0)
Glucose Intolerance and Hyperinsulinemia in Familial Combined Hyperlipidemia (1996) (0)
A Case of Heterozygous Familial Hypercholesterolemia Associated with Hyperthyroidism: Effects of Triiodothyronine on the Degradation of Low Density Lipoprotein by Cultured Human Skin Fibroblasts (1982) (0)
Double Missense Mutations (D611Y in KCNQ1 and D609G in HERG) in a Japanese Family with Long QT Syndrome (2003) (0)
Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention (2021) (0)
[Normotriglyceridemic abetalipoproteinemia]. (1998) (0)
[Apolipoprotein B-100 variants]. (1998) (0)
Abstract: 18 CLINICAL USE OF STATINS (2009) (0)
3.P.344 Coronary artery calcification and coronary atherosclerosis in familial hypercholesterolemia: Electron beam computed tomographic study (1997) (0)
Long-term effects of fluvastatin on serum lipids and apolipoprotein levels in patients with familial hypercholesterolemia (1994) (0)
The Patient Characteristics of the Hyper-responder to Low Dose Statin Treatment in J-LIT Study (2002) (0)
Angiotensin II Type 1 Receptor A/C1166 Gene Polymorphism and Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy with Sarcomere Gene Mutations(Cardiomyopathy, Clinical 7 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Polycystin-L is a voltage dependent and non-selective cation channel (2004) (0)
[Idiopathic enlargement of the right atrium]. (1996) (0)
New LDL-receptor gene mutant in two homozygous familial hypercholesterolemia sisters showing relative longevity (1994) (0)
Effects of Heparin on Plasma Lipid and Lipoproteins (1975) (0)
Whole and regional variation of cardiac sympathetic nervous activity in patients with hypertrophic cardiomyopathy with malignant tachyarrthythmias and sudden death (2002) (0)
Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolism. (2022) (0)
The Japan Atherosclerosis Society Guideline for Diagnosis and Managementy of Hyperlipidemia for Precention of Atherosclerosis: ―1998年調査と反応― (1999) (0)
[Early effects of egg yolk ingestion on serum lipids and lipoproteins (author's transl)]. (1979) (0)
[Primary hypercholesterolemia]. (1990) (0)
Abstract: P919 FORMATION OF PREB1-HDL DURING LIPOLYSIS OF TRIGLYCERIDERICH LIPOPROTEIN (2009) (0)
Diagnostic Values of Abnormal Q Waves for Hypertrophic Cardiomyopathy Based on the Genetic Information (2003) (0)
Abstract 14785: Impact of Impaired LDL Catabolism and Increased VLDL and VLDL Remnant Production on Hypercholesterolemia in Homozygous PCSK9 Gene Mutation: Evidence from Kinetic Study with Stable Isotope (2011) (0)
M.644 Differences in coronary event risk factors between men and women in Japanese hypercholesterolemic patients treated with low-dose simvastatin (2004) (0)
Distribution of QTc Values and Prevalence of Short QT Syndrome in the Japanese Population (ECG/Body Surface Potential Mapping/Holter 6 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Subject Index Vol. 72, 1996 (1996) (0)
Relationship between QT Variables and Disproportion of Left Ventricular Wall in Patients with Hypertrophic Cardiomyopathy (2002) (0)
PCSK9 Gene Mutation is Less Frequent in Clinically Diagnosed FH Patients without LDLR and ApoB-100 Gene Mutation in Japan(Lipid Disorders 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
M.603 The risk of coronary heart disease in hypercholesterolemic patients with diabetes mellitus and impaired fasting glucose in Japanese population ? Sub-analysis of the J-lit study, a large-scale observational cohort study (2004) (0)
Lecithin: Cholesterol Acyltransferase Activity in Patients with Chronic Renal Failure (1980) (0)
Abstract 17868: Role of Lysosomal Acid Lipase in LDL-C Regulation in Familial Hypercholesterolemia and Metabolic Syndrome (2015) (0)
[Long-term survival in cases of basilar artery occlusion]. (1976) (0)
P238 ONSET OF CORONARY ARTERY DISEASE IN PATIENTS WITH AND WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA IN JAPAN (2010) (0)
Mitochondrial DNA Mutations in Hypertrophic Cardiomyopathy (2002) (0)
Contents, Vol. 50, 1986 (1986) (0)
STUDIES ON THE ATHEROSCLEROSIS : Effect of Dietary Carbohydrates on Arterial Lesions in the Rabbit (1969) (0)
MTP inhibitors have prominent effects in lowering LDL cholesterol levels in patients with homozygous familial hypercholesterolemia. (2013) (0)
Atrial fibrillation in patients with severe aortic stenosis. (2022) (0)
[Familial defective apolipoprotein B-100]. (1998) (0)
[Cholesteryl ester transfer protein deficiency]. (2001) (0)
[Accessory mitral valve in the aged]. (1996) (0)
Cholesteryl Ester Transfer Protein (CETP) and Atherogenicity. Anti-atherogenicity of CETP deficiency is dependent on serum HDL cholesterol levels. (1998) (0)
3.P.340 Effects of apolipoprotein E polymorphism on early carotid and brachial atherosclerosis evaluated by high-resolution ultrasonography (1997) (0)
Coronary lesion morphology and prognosis in young myocardial infarction males with or without familial hypercholesterolemia (2000) (0)
-532- CORONARY ANGIOGRAPHIC CHARACTERISTICS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (1987) (0)
Characteristics of Coronary Artery Disease in Patients with Familial Hypercholesterolemia (1985) (0)
[6 cases of familial hypercholesterolemia with spontaneous rupture of Achilles tendon]. (1983) (0)
Japan Lipid Intervention Trial (J-LIT) Chart Predicts the Absence of Coronary Artery Disease More Accurately Than Symptom Limited Exercise Stress Electrocardiography (2003) (0)
Synergistic Effects of Hepatic Lipase (HL) Promoter And CETP Promoter Polymorphism on Increased HDL-C Levels in Both Gender(Metabolism/Biochemistry/Energetics 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Abstract 9600: Abnormal Lipoprotein Metabolism Other Than LDL Fraction in Familial Hypercholesterolemia: Serial analysis using Ultracentrifugation Method (2014) (0)
Apolipoprotein(a) phenotype in patients with coronary artery disease (2000) (0)
Clinic of hyperlipidemia. (1999) (0)
Molecular mechanism of low density lipoprotein oxidation by 12-lipoxygenase-overexpressing macrophages (2002) (0)
Lipoprotein lipase gene analysis in Japanese patients with familial combined hyperlipidemia (1999) (0)
ALDOSTERONE IS THE MAJOR RISK FACTOR FOR THE PROGRESSION OF RENAL INJURY IN HYPETENSIVE PATIENTS TREATED WITH ANGIOTENSIN-II RECEPTOR BLOCKER: OP 129 (2004) (0)
Efficacy of Endoscopic Esophageal Variceal Ligation in an Immunocompromised Host (1996) (0)
5,10-methylenetetranhydrofolate reductase 677 C→T mutation may be a genetic risk factor in Budd-Chiari syndrome (1998) (0)
LDL Receptor Gene Mutations in Japanese Patients with Familial Hypercholesterolemia (1989) (0)
PJ-366 Cyclic AMP-mediated Inhibitory Regulation of Rac Activation and Cell Migration by the EP2 subtype of Prostagalandin E2 (PGE2) Receptors in Vascular Smooth Muscle(Molecular Biology, Vascular 2 (H) : PJ61)(Poster Session (Japanese)) (2004) (0)
QT Variables in Various Genotyped Patients with Hypertrophic Cardiomyopathy (2003) (0)
MAXIMUM LIPID-LOWERING THERAPY FOR FAMILIAL HYPERCHOLESTEROLEMIA: EFFICACY AND SAFETY WITH HIGH-DOSE STATIN, RESIN AND EZETIMIBE (2008) (0)
[Abnormal apolipoprotein B]. (1998) (0)
Abstract 8252: Altered Metabolism of Post-Prandial Remnant Lipoprotein Fractions in Autosomal Recessive Hypercholesterolemia (2011) (0)
Abstract 10252: Lipoprotein (a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin Kexin Type 9 Gain-of-function Mutations (2015) (0)
[Clinical studies on hyperlipidemia]. (1999) (0)
Molecular Genetics of Cholesterol Transport and Cholesterol Reverse Transport Disorders, and Coronary Heart Disease (1996) (0)
Relationship between Plasma Homocysteine Concentrations and Arteriosclerotic Risk Factors in Type II Diabetes Mellitus. (1999) (0)
16% of familial hypercholesterolemia in the Hokuriku District of Japan can be explained by seven mutants of LDL-receptor gene (1994) (0)
2P-0602 Effects of colestimide in addition to atorvastatin on low-density lipoprotein (LDL) cholesterol in patients with heterozygous familial hypercholesterolemia (FH) (2003) (0)
2P-0606 Long-term effects of LDL-apheresis treatment and morphologic changes of coronary atherosclerotic lesions in two brothers of homozygous patients with familial hypercholesterolemia (2003) (0)
Adult Patient With Isolated Noncompaction of Ventricular Myocardium (2005) (0)
[Functioning test for cholesterol turnover]. (1997) (0)
Common functional variant LIPA T16P affects HDL composition among patients with heterozygous familial hypercholesterolemia. (2017) (0)
Abstract 20674: Genetic CETP Deficiency Associated With Higher eGFR and Lower Coronary Stenosis Index in Dyslipdemic Patients in Japan (2014) (0)
Differences in Diagnostic Values of Abnormal Q Waves between Hypertrophic Cardiomyopathy with a cTnl Gene Mutation and MyBP-C Gene Mutations (2003) (0)
[Lipid metabolism abnormalities and progress in their treatment]. (2001) (0)
Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry. (2022) (0)
Genotype-phenotype correlation in Japanese patients with Wilson's disease (1998) (0)
Serum Lipid, Lipoprotein and Apoprotein Levels in Thyroid Disease (1986) (0)
Abstract 18715: Clinical Characteristics of Double Heterozygotes With PCSK9 Gain-of-Function Mutations and LDLR Mutations (2016) (0)
Gene analysis of ATP7B in japanese patients with wilson's disease (2000) (0)
Frequency of Asymmetric Septal Hypertrophy in Patients with Hypertrophic Cardiomyopathy : Difference in Genotypes (2003) (0)
[Restriction fragment length polymorphisms in apolipoprotein genes in diabetes mellitus]. (1991) (0)
Studies on Serum and Urine Volatile Substance : Part II (1968) (0)
benzoxathiepins with an aminoalkyl group at the 2-, 3-, or 4-position and related compounds, and the structure-activity relationships of S2-receptor-blocking activity. Synthesis of Aminoalkyl-Substituted 1,5-Benzoxathiepin Derivatives and Related Compounds In the previous paper, we reported a novel (2009) (0)
Clinical implication of FH gene test: Detection rates in LDLR and PCSK9 genes in Japan (2018) (0)
Abstract 9712: Lack of Association Between Common p.T111I Variant in the Endothelial Lipase Gene and the Risk for Coronary Artery Disease in Familial Hypercholesterolemia: Insights From the Modulation of Phospholipids in the HDL Particles (2011) (0)
Identification of novel missense variants in the coding region of peroxisome proliferator-activated receptor alpha in the patients with primary hyperlipidemia (2000) (0)
Effects of LDL-Apheresis on Coronary Artery Stenosis in Patients with Familial Hypercholesterolemia (1989) (0)
Q-T peak dispersion in congenital long QT syndrome ; increased lag of T wave peak as a new marker of HERG (2002) (0)
Noninvasive detection of coronary atherosclerosis by ultrafast computed tomography: comparison with electrocardiographic and radionuclide exercise stress tests (1994) (0)
[Plasmapheresis in familial hypercholesterolemia and bone marrow transplantation from an ABO incompatible donor]. (1981) (0)
Long QT Syndrome Mutations in Different Sites of HERG Elicit a Variety of Functional Changes (2003) (0)
Fluctuation of T-peak to T-end before and after ventricular tachycardia (2002) (0)
Abstract 1085: Impact of Functional Promoter Variant of XBP1 Gene on Lipid and Glucose Metabolism in Japanese Population (2009) (0)
Cardiac Actin and Alpha-Tropomyosin Genes Are Associated with Neither Hypertrophic Nor Dilated Cardiomyopathy in Patients from Hokuriku District in Japan (2003) (0)
VALIDATION OF CLINICAL DIAGNOSTIC CRITERIA OF FAMILIAL HYPERCHOLESTEROLEMIA IN JAPAN: EVIDENCE FROM A COMPREHENSIVE GENETIC ANALYSIS (2019) (0)
Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry. (2020) (0)
M.575 Rosuvastatin produces substantial improvements in the lipid profile of Japanese patients with heterozygous familial hypercholesterolemia (2004) (0)
THU0094 Experimental mycoplasma fermentans infection in rheumatoid synovial fibroblasts induces m161ag expression (2001) (0)
The risk of coronary heart disease, stroke or total cardiovascular events in hypertensive patients with hypercholesterolemia in Japanese population - sub-analysis of the J-LIT study, a large-scale observational cohort study (2004) (0)
Arteriosclerotic cholesterol lowering therapy. (1998) (0)
Abstract: P852 SYNERGISTIC IMPACT OF FARNESOID X RECEPTOR AND UPSTREAM TRANSCRIPTION FACTOR 1 GENE VARIANTS ON LIPOPROTEIN METABOLISM (2009) (0)
Removal of Plasma Low Density Lipoprotein by Adsorption Chromatography with Porous Glass (1982) (0)
Running title: Stitziel et al., Exome Sequencing in Monogenic Dyslipidemias (2015) (0)
[Studies on simple methods for quantitation of "serum beta-lipoprotein" (author's transl)]. (1978) (0)
Effect of Glycemic Control During Follow-up on Late Target Lesion Revascularization After Implantation of New-Generation Drug-Eluting Stents in Patients With Diabetes　― A Single-Center Observational Study ― (2020) (0)
[New assay method for hepatic lipase activity]. (2007) (0)
Regional difference of LDL receptor gene mutations in Japanese patients with familial hypercholesterolemia (2000) (0)
New treatment for eradication of Helicobacter pylori: effective and inexpensive combination (2000) (0)
A 4-year trial of simvastatin in the treatment of patients with heterozygous familial hypercholesterolemia (1996) (0)
2P-0608 Influence of aging on serum cholesterol levels in heterozygous familial hypercholesterolemia patients with long-term LDL apheresis therapy (2003) (0)
Diabetic patients assosiated with positive GAD-antibodies and mitochondrial DNA abnormality in Japan. (1997) (0)
Abstract 18745: Triglyceride-Rich High-Density Lipoprotein Composition as Residual Risk Biomarker of Coronary Artery Disease Including Reduced eGFR and Pre-diabetes (2012) (0)
3102Comprehensive genotyping and phenotyping in patients with severe hypercholesterolemia (2017) (0)
4.P.37 Coronary calcification and regression of coronary atherosclerosis by long-term LDL-apheresis in patients with heterozygous familial hypercholesterolemia (1997) (0)
Concomitant Mitral Regurgitation in Severe Aortic Stenosis (2021) (0)
Usefulness of Acoustic Densitometry Method for Detection of Myocardial Changes in Preclinical Patients with Hypertrophic Cardiomyopathy (2003) (0)
IMPACT OF ELEVATED PCSK9 LEVELS ON REGULATION OF LDL-CHOLESTEROL AFTER STATIN TREATMENT: STUDY WITH DIFFERENT TYPES OF LIPID LOWERING DRUGS (2011) (0)
-0954-ABDOMINAL ARTIC ANEURYSM OF FAMILIAL HYPERCHOLESTEROLEMIA : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
Abstract: 66 ELEVATED PLASMA LEVELS OF MATRIX MATAROPROTEINASE (MMP)-2, MMP-9 AND TIMP-1 IN PATIENTS WITH PSEUDOXANTHOMA ELASTICUM (PXE) (2009) (0)
Analysis of Lipoprotein Patterns and VLDL Apolipoprotein C and E Isoform of Patients with Acute Myocardial Infarction (1984) (0)
OE-210 A New Method for Determining Functional LDL-C Receptor Activity in Hypercholesterolemic Patients : Application of CD3/CD28 Assay in Lymphocytes(Lipid disorders(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
[Primary hyperlipoproteinemia type 3]. (1983) (0)
[Metabolic anomaly of obesity: therapeutic results of combined diet and chemotherapy]. (1974) (0)
[The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)]. (1981) (0)
Studies on Arteriosclerosis ; Role of Capillary Permeability Accelerating Factor which Contained in Kidney Cortex (1967) (0)
Diagnostic Usefullness of Achilles Tendon Thickness of Familial Hypercholesterolemia (FH) With Low-density-lipoprotein Receptor (LDLR) Gene Mutation(Lipid Disorders 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention. (2022) (0)
Ischemic Heart Disease and Lecithin: Cholesterol Acyl Transferase Activity (1979) (0)
A novel de novo mutation in the cardiac β - myosin heavy chain gene in patients with dilated cardiomyopathy (2002) (0)
Th-P16:388 Effects of dietary COQ10 supplementation on serum lipid, COQ10 and liver enzyme levels in hypercholesterolemic patients treated with atorvastatin (2006) (0)
[Serum lipoprotein and LDL pathway in familial hypercholesterolemia (author's transl)]. (1980) (0)
Genetic cetp deficiency associated with lower coronary stenosis index in dyslipdemic patients in japan (2014) (0)
日本における高脂血症の脂質低下治療の現状:高脂血症治療の現状調査(J‐LAP) (2003) (0)
Abstract 8511: A Novel Type of Homozygous Familial Hypercholesterolemia:Double Heterozygous Mutations in LDL Receptor and LDL Receptor Adaptor Protein 1 Gene (2011) (0)
[EBER-1 expression in salivary glands of Sjögren's syndrome]. (1995) (0)
On finishing the editorial work (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hiroshi G. Mabuchi?

Hiroshi G. Mabuchi is affiliated with the following schools:

Kanazawa University